Daily Stock Analysis, CSII, Cardiovascular Systems Inc, priceseries

Cardiovascular Systems Inc. Daily Stock Analysis
Stock Information
Open
22.40
Close
22.49
High
22.79
Low
22.10
Previous Close
22.50
Daily Price Gain
-0.01
YTD High
27.80
YTD High Date
Jan 24, 2018
YTD Low
20.58
YTD Low Date
Feb 14, 2018
YTD Price Change
-1.75
YTD Gain
-7.22%
52 Week High
33.11
52 Week High Date
Jul 20, 2017
52 Week Low
20.58
52 Week Low Date
Feb 14, 2018
52 Week Price Change
-6.70
52 Week Gain
-22.95%
Company Information
Stock Symbol
CSII
Exchange
NasdaqGS
Company URL
http://www.csi360.com
Company Phone
651-259-1600
CEO
Scott R. Ward
Headquarters
Minnesota
Business Address
1225 OLD HWY 8 NW, ST. PAUL, MN 55112
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001180145
About

Cardiovascular Systems, Inc. is a medical device company, which develops and sells devices for treating cardiovascular diseases. It focuses on developing and commercializing minimally invasive treatment solutions for vascular diseases. The company's products such as diamondback 360 ー PAD system and the stealth 360 ー PAD system are catheter based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee. The company was founded in 2000 and is headquartered in St. Paul, MN.

Description

Cardiovascular Systems, Inc., a medical technology company, develops, manufactures, and markets devices to treat vascular diseases in the United States. It offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System (OAS), Stealth 360 Peripheral OAS, Diamondback 360 60cm Peripheral OAS, Diamondback 360 Low Profile Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, and Diamondback 360 2.00 Peripheral OAS, which are catheter-based platforms for treating a range of plaque types, such as calcified plaque, in leg arteries both above and below the knee and address many of the limitations associated with other surgical, catheter, and pharmacological treatment alternatives, as well as Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries. The company sells its products directly to hospitals or office-based labs. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.